SEC 13F Intelligence

Sassicaia Capital Advisers LLC / XLRN

Sassicaia Capital Advisers LLC’s Acceleron Pharma Inc Position

Does Sassicaia Capital Advisers LLC own Acceleron Pharma Inc (XLRN)? Not currently — the last reported position was 3.8K shares worth $654,000 in Q3 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$654,000
Q3 2021
Shares
3.8K
% of Portfolio
+1.85%
Quarters Held
1
position exited

Position History XLRN

Reported value by quarter
Q3 ’21: $654,000Q3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20213.8K$654,000+1.85%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sassicaia Capital Advisers LLC’s full portfolio or all institutional holders of XLRN.